I
Transmembranous Klotho
The anchored form, bound into the cell membrane where it partners with FGF receptors.
Kidney · Parathyroid · Brain
Specimen № 01 · α-Klotho · FGF23 Co-receptor
The Longevity Protein
Medicine Forgot
A field guide to Klotho peptide therapy: the anti-aging protein discovered in 1997, and still absent from the syllabus.
Alpha-Klotho was first identified in 1997. Nearly three decades later, long after it was tied to how we age, move, and think, it is still not taught in most medical schools. It is a co-receptor in the endocrine fibroblast growth factor (FGF) system, a quiet governor of the pathways that decide how gracefully a body grows old.
Mechanism
One protein, many switchboards
As a component of the endocrine FGF receptor complex, Klotho helps regulate a remarkable spread of enzymatic pathways, the housekeeping systems that keep a cell young.
It is called an age-inhibitor for a plain reason: when Klotho runs low, the body starts to wear the phenotypes of age: sarcopenia, osteoporosis, impaired cognition, gait disturbance, atherosclerosis, neurodegeneration, fibromyalgia.
Three Isoforms
Where Klotho lives, and how it travels
II
Secreted Klotho (s-Klotho)
Cleaved and released to act as a circulating hormone with pleiotropic, whole-body effects.
Plasma · Urine · Cerebrospinal fluid
III
Intracellular Klotho
The easiest isoform to measure, and the one observed to fall steadily from around age 40, on the same curve as NMN and most other healing molecules.
Declines from ≈ age 40
The Correlation Ledger
What rises with it, what falls
+ Rises with Klotho
- Muscle strength
- Muscle performance
- Healthy body mass index
– Falls with Klotho
- Osteoporosis
- Impaired mobility
- Chronic inflammation
- Chronic pain
- All-cause mortality
In the video, Dr. Schuster describes Klotho turning on and tuning the pathways longevity science keeps returning to:
“Why is this stuff not being taught in every single medical school? Because these molecules are not patentable. They're natural.”— Dr. Jason Schuster, on why Klotho stays off the syllabus
Reported Effects
What people using it describe
A natural, non-patentable peptide, available now, and (as Dr. Schuster notes) under active pressure from regulators. Those using it report:
Slows age-related decline
Limits inflammation
Limits oxidative stress
Supports mental health
Cardiovascular protection
Preserves metabolic flexibility
Guards against age-related disease
Continuing Education
Go deeper than the summary
Dr. Schuster's board-certified, accredited peptide therapy course: 5 CEUs of peer-reviewed research, full dosing protocols, and video breakdowns.